Primum Non Nocere: Serial Screening for AF, Who, How, and Why?

Competing Interests: Funding Support and Author Disclosures Dr Sanders is supported by a Practitioner Fellowship from the National Health and Medical Research Council of Australia. Dr Kamsani is supported by the National Heart Institute, Malaysia. Dr Sanders has served on the advisory board for Boston Scientific, CathRx, Medtronic, Abbott Medical, and Pacemate; has received lecture and/or consulting fees from Medtronic, Boston Scientific, Abbott Medical, Pacemate and CathRx, all of which the University of Adelaide received on his behalf; has received research funding from Medtronic, Abbott Medical, Boston Scientific, Pacemate, Becton Dickinson, and MicroPort, all of which the University of Adelaide received on his behalf. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.